Page last updated: 2024-08-24

zanamivir and Myelodysplastic Syndromes

zanamivir has been researched along with Myelodysplastic Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, O; Gkioule, C; Grund, S; Kobbe, G; Pfeifer, N; Termos, T; Verheyen, J1
Carrington, D; Clark, A; Johny, AA; Marks, DI; Oakhill, A; Price, N1

Trials

1 trial(s) available for zanamivir and Myelodysplastic Syndromes

ArticleYear
The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Antiviral Agents; Female; Guanidines; Hematologic Neoplasms; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Myelodysplastic Syndromes; Pyrans; Sialic Acids; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Zanamivir

2002

Other Studies

1 other study(ies) available for zanamivir and Myelodysplastic Syndromes

ArticleYear
Primarily oseltamivir-resistant influenza A (H1N1pdm09) virus evolving into a multidrug-resistant virus carrying H275Y and I223R neuraminidase substitutions.
    Antiviral therapy, 2015, Volume: 20, Issue:1

    Topics: Amino Acid Substitution; Antiviral Agents; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Mutation; Myelodysplastic Syndromes; Neuraminidase; Oseltamivir; Viral Proteins; Zanamivir

2015